Dr. Ramineni Naga Tejaswini: Championing Early Diagnosis and Innovation in Autoimmune Care
- Sudeep Immunyfit
- Nov 11, 2025
- 2 min read
The Capital Information newspaper recently featured Dr. Ramineni Naga Tejaswini, Consultant Rheumatologist and Clinical Immunologist at Apollo Hospitals, Jubilee Hills, Hyderabad, for her efforts in raising awareness about the growing threat of autoimmune diseases among India’s youth. The article, titled “Rising Autoimmune Diseases Threaten India’s Young — But Hope Remains Strong,” sheds light on an alarming trend while offering a message of optimism and resilience.

The Growing Concern
Dr. Tejaswini highlights that a rising number of young Indians in their 20s, 30s, and 40s are being diagnosed with autoimmune and musculoskeletal disorders such as rheumatoid arthritis (RA), lupus, scleroderma, and juvenile idiopathic arthritis. These diseases, if left untreated, can damage joints, organs, and severely impact quality of life.
She notes that despite the challenges, early diagnosis and timely intervention can change the course of these conditions entirely. Many patients, however, seek medical help only after months or years of symptoms—by which time joint damage and organ involvement have already begun.
“Simple blood tests and clinical evaluation can help identify autoimmune diseases early. If treatment begins within the first few months, we can completely prevent deformities and maintain full function,”says Dr. Ramineni Naga Tejaswini.
Raising Awareness for World Arthritis Day
In the lead-up to World Arthritis Day (October 12, 2025), Dr. Tejaswini and fellow rheumatologists in Hyderabad are urging the public to recognize early warning signs—joint pain lasting over four weeks, persistent swelling, and skin rashes—and to seek medical care promptly. This year’s global theme, “Achieve Your Dreams,” resonates with her message that with the right treatment and lifestyle support, patients can continue to live fulfilling, productive lives.
The Immunyfit Vision
Beyond her clinical practice, Dr. Tejaswini extends her mission through Immunyfit, a health technology initiative that redefines how autoimmune and gut-immune conditions are understood and managed.
Immunyfit’s platform takes a systems biology and AI-driven approach to health by creating a Digital Twin of a person’s immune profile—mapping symptoms, biomarkers, gut health, and lifestyle factors. This allows for personalized interventions that target the root causes of immune dysfunction rather than merely managing symptoms.
This philosophy aligns seamlessly with Dr. Tejaswini’s clinical insights: early diagnosis, personalized care, and preventive medicine are the cornerstones of lasting wellness.
Hope and Progress
The feature in Capital Information underscores a vital message—autoimmune diseases are on the rise, but with awareness, innovation, and commitment from experts like Dr. Tejaswini, there is real hope for change. Her dual role as a clinician and innovator bridges traditional medicine with modern health technology, offering a future where autoimmune care becomes more predictive, personalized, and preventive.


Comments